Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

INBX holding history

Inhibrx Biosciences, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

INBX overviewAll 13F holders of INBXFull Q2 2026 holdings

Shares (Q2 2026)
256,175
Value
$24.3M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of INBX by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026256,175$24.3M<0.1%+24,666+10.7%AddedHolders
Q1 2026231,509$15.6M<0.1%+5,500+2.4%AddedHolders
Q4 2025226,009$17.9M<0.1%+4,089+1.8%AddedHolders
Q3 2025221,920$7.48M<0.1%−4,035−1.8%ReducedHolders
Q2 2025225,955$3.23M<0.1%−34,074−13.1%ReducedHolders
Q1 2025260,029$3.64M<0.1%+4,896+1.9%AddedHolders
Q4 2024255,133$3.93M<0.1%+3,914+1.6%AddedHolders
Q3 2024251,219$3.93M<0.1%+40,902+19.4%AddedHolders
Q2 2024210,317$2.98M<0.1%−494,508−70.2%ReducedHolders
Q1 2024704,825$24.6M<0.1%+17,465+2.5%AddedHolders
Q4 2023687,360$26.1M<0.1%+41,201+6.4%AddedHolders
Q3 2023646,159$11.9M<0.1%−12,864−2.0%ReducedHolders
Q2 2023659,023$17.1M<0.1%+49,206+8.1%AddedHolders
Q1 2023609,817$11.5M<0.1%+34,120+5.9%AddedHolders
Q4 2022575,697$14.2M<0.1%+78,890+15.9%AddedHolders
Q3 2022496,807$8.92M<0.1%+63,688+14.7%AddedHolders
Q2 2022433,119$4.92M<0.1%−17,321−3.8%ReducedHolders
Q1 2022450,440$10.0M<0.1%+20,558+4.8%AddedHolders
Q4 2021429,882$18.8M<0.1%−16,341−3.7%ReducedHolders
Q3 2021446,223$14.9M<0.1%+126,382+39.5%AddedHolders
Q2 2021319,841$8.80M<0.1%+169,371+112.6%AddedHolders
Q1 2021150,470$3.02M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.